The use of topographical constraints in receptor mapping: Investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and δ-opioid receptors

Lakmal W. Boteju, Gregory V. Nikiforovich, Carrie Haskell-Luevano, Su Nan Fang, Teresa Zalewska, Dagmar Stropova, Henry I. Yamamura, Victor J. Hruby

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The cholecystokinin (26-33) [CCK (26-33)] octapeptide analog Asp-Tyr-D- Phe-Gly-Trp(N-Me)-Nle-Asp-Phe-NH2 (SNF 9007) is a potent and selective ligand for both the CCK-B and δ-opioid receptors. Pharmacological studies of SNF 9007 suggest a relationship between the ligand requirements of CCK-B and δ-opioid receptors, which further implies a possible structural relationship between these receptors. We have utilized topographical constrainment of the important Trp30 residue to investigate structural features of SNF 9007 that would distinguish between binding requirements in this region for the CCK-B and δ-opioid receptors. Thus, the four optically pure isomers of β-MeTrp were substituted for L-Trp30 of SNF 9007. Receptor binding results suggest that the preferred topography of the Trp30 residue for CCK-B receptor binding may be the 2S,3S (erythro-L) configuration whereas for the δ-opioid receptor it may be the 2S,3R(threo-L)configuration. Molecular modeling studies of these ligands further support the recently revised receptor-bound model for CCK-B octapeptide ligands (Kolodziej et al. J. Med. Chem. 1995, 38, 137-149) and are in good agreement with the DPDPE-δ opioid receptor 'template' model (Nikiforovich et al. Biopolymers 1991, 31,941-955).

Original languageEnglish (US)
Pages (from-to)4120-4124
Number of pages5
JournalJournal of Medicinal Chemistry
Volume39
Issue number20
DOIs
StatePublished - Sep 27 1996

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'The use of topographical constraints in receptor mapping: Investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH<sub>2</sub> (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and δ-opioid receptors'. Together they form a unique fingerprint.

Cite this